Night and low-contrast vision with three types of intraocular lenses
Official title: Clinical Evaluation of Low Contrast Defocus Curves, Low Light Photic Phenomena, and Dysphotopsia Profiles in Pseudophakic Patients
Run by Empire Eye and Laser Center · NCT07213167 · Data updated 2026-11-12
This study will test how three different intraocular lenses affect night vision, low-contrast vision, and related symptoms in people who had cataract surgery.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 22 Years and up |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Empire Eye and Laser Center Academic / other |
| Locations | 1 site (Bakersfield, California) |
| Status | Recruiting |
| Started | September 24, 2025 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | September 25, 2026 |
| Trial ID | NCT07213167 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults (≥22 years) who are bilaterally pseudophakic at least three months after IOL implantation, can complete vision testing, and can read and respond in English.
✕Probably not a fit
People with uncorrected distance visual acuity worse than 20/25, significant pupil abnormalities, unstable fixation (for example nystagmus), prior corneal refractive surgery, or who cannot complete the tests are unlikely to benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study compares visual function and nighttime photic phenomena across three commonly used intraocular lens (IOL) models using device-based tests and patient questionnaires. Participants complete two vision questionnaires (PRVSQ v2 and AIOLIS in randomized order) and undergo a battery of tests including low- and high-contrast defocus curves, halometry at multiple light levels and colors, contrast sensitivity, pupilometry, and standard acuity and slit-lamp exams. Primary endpoints are the 50% low-contrast defocus curve, objective halometry measurements under cool white light, and PRVSQv2 results, with secondary outcomes covering a wide set of visual performance and satisfaction measures. The study enrolls adults at least three months after bilateral IOL implantation and aims to correlate objective device measures with patient-reported symptoms.
Why it matters
Potential benefit: If successful, the results could help doctors and patients choose IOLs that provide better night and low-contrast vision and reduce bothersome visual symptoms.
How similar studies have gone: Other observational comparisons of IOL performance and the use of halometry have been reported, but the combined correlation of low-contrast defocus curves, multicolor halometry, and detailed patient-reported dysphotopsia profiles is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Minimum 22 years of age * Bilateral pseudophakia, at least 3 months postoperative from IOL implantation, with one of the study IOL models in at least one eye. * Availability, willingness, and sufficient cognitive awareness to comply with examination procedures * Signed informed consent and HIPAA authorization or equivalent documentation necessary to comply with applicable privacy laws pertaining to medical treatment in the governing countries * Ability to understand and respond to a questionnaire in English Exclusion Criteria: * Any clinically significant pupil abnormalities (non-reactive, fixed pupils, or abnormally shaped pupils. * Inability to focus or fixate for prolonged periods of time (e.g., due to strabismus, nystagmus, etc.) * Uncorrected distance visual acuity worse than 20/25 in either eye * Prior corneal refractive surgery (LASIK, LASEK, RK, PRK, etc.) or intraocular surgery. Note: Prophylactic peripheral iridotomies and peripheral laser retinal repairs that, in the opinion of the investigator will not confound study outcomes are acceptable. * Posterior capsular opacification with grading worse than 1+ * Ocular findings that may, in the opinion of the investigator, affect vision and/or contrast sensitivity
Where it's running
-
Empire Eye and Laser Center
Bakersfield, California, United States Recruiting
Study contacts
- Principal investigator: Daniel H Chang, MD — Empire Eye and Laser Center
- Study coordinator: Brittany M Camirand
- Email: bcamirand@empireeyeandlaser.com
- Phone: 661-301-6211
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Wavefront-Guided LASIK with a 10 MHz Elita Laser in Myopic Eyes
This study tests whether using a 10 MHz Elita femtosecond laser for wavefront-guided LASIK in people with myopia or myopic astigmatism can achieve 6–12 month outcomes comparable to or better than prior myopic LASIK results.
-
Comparison of ACUVUE OASYS MAX 1-Day Multifocal vs DAILIES AquaComfort Plus Multifocal
This study tests two daily multifocal contact lenses in adults 40–70 to see which provides better vision and comfort while wearing them regularly.
-
tDCS for paediatric amblyopia
This study tests whether non-invasive brain stimulation (tDCS) can improve vision for children aged 4–14 with amblyopia who didn’t get enough help from patching.
-
Metric-Optimized Glasses for Children with Down Syndrome
This study tests whether glasses prescribed from computer analysis of eye images help improve vision in children with Down syndrome more than glasses prescribed by standard eye exams.
-
Natural history of inherited retinal diseases
This project will test whether color vision problems relate to retinal structure and visual function in people with inherited retinal dystrophies and in people without retinal disease.
-
Deep-learning eye-tracking vision screening for infants, preschoolers, and children with special needs
This project will try a deep-learning eye-tracking system to measure visual acuity and visual field in infants under 3, preschoolers aged 3–5, and children with developmental disabilities, using adults as a reference group.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.